摘要
目的探讨及研究微量催产素静脉滴注在无痛分娩中的应用价值。方法选取2012年6月至2013年5月于本院进行无痛分娩的110例产妇为研究对象,将其随机分为对照组(常规干预组)55例和观察组(常规干预加微量催产素组)55例,然后将两组中初产妇和经产妇的各个产程时间及转剖宫产率、产后不良情况发生率进行比较。结果观察组中初产妇和经产妇的各个产程时间均短于对照组,转剖宫产率、产后不良情况发生率也均低于对照组,P均<0.05,两组间均有显著性差异。结论微量催产素静脉滴注在无痛分娩中的应用价值较高,可明显缩短产程及降低不良情况发生率。
Objective To study and discuss the application value of microoxytocin intravenous infusion in patients with painless labor. Method Select 110 cases of puerpera who were chosing painless labor from June 2012 to May 2013 in our hospital as study objects, and divided them into two groups randomly, control group：（conventional intervention group） 55 cases, and the observation group：（conventional intervention plus microoxytocin group） 55 cases. Then each labor time of primipara and multipara, the transfer rate of cesarean section,and the incidence of postpartum adverse situation of the two groups were compared. Results Each labor time of primipara and multipara of the observation group were shorter than the control group, the transfer rate of cesarean section, postpartum adverse cicurmstances happening rate were lower than those in the control group, there was a significant difference between the two groups（P〈0.05）. Conclusion The application value of microoxytocin intravenous infusion in puerpera with painless labor is high, it can apparently shorten the production process and decrease the incidence of adverse circumstances.
出处
《中国医药指南》
2013年第35期331-332,共2页
Guide of China Medicine
关键词
微量催产素
静脉滴注
无痛分娩
应用价值
Microoxytocin
Intravenous infusion
Painless labor
Application value
